COVID-19 screening before gastrointestinal procedures
Abstract Background In March 2020, the World Health Organization declared coronavirus 2019 (COVID-19) a global pandemic. We aimed to assess the ability of COVID-19 screening to detect preprocedural infection at the gastrointestinal units. One hundred and three patients indicated for gastrointestinal...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-02-01
|
Series: | Egyptian Liver Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43066-022-00177-0 |
_version_ | 1819274977531133952 |
---|---|
author | Ahmed Eliwa Osman Mohamed Osman Ahmed Helal Abdelgawad Saied Mohamed Mohammed ElFayoumie Ramadan Eldamarawy Sadek Mostafa Ashraf Elsharkawy Khaled S. Makboul Salwa I. Elshennawy Mahmoud Abdelhady Ashraf Elbahrawy |
author_facet | Ahmed Eliwa Osman Mohamed Osman Ahmed Helal Abdelgawad Saied Mohamed Mohammed ElFayoumie Ramadan Eldamarawy Sadek Mostafa Ashraf Elsharkawy Khaled S. Makboul Salwa I. Elshennawy Mahmoud Abdelhady Ashraf Elbahrawy |
author_sort | Ahmed Eliwa |
collection | DOAJ |
description | Abstract Background In March 2020, the World Health Organization declared coronavirus 2019 (COVID-19) a global pandemic. We aimed to assess the ability of COVID-19 screening to detect preprocedural infection at the gastrointestinal units. One hundred and three patients indicated for gastrointestinal tract interventional procedures were included. All patients surveyed for COVID-19-related symptoms and COVID-19 rapid IgM/IgG antibodies. Symptomatic and COVID-19 antibody-positive patients further tested for COVID-19 reverse transcriptase by polymerase chain reaction (RT-PCR). All patients contacted, 14 days after the procedure and asked about the possible development of COVID-19. All health care workers (HCWs) (n=18) were screened weekly for COVID-19-related symptoms. Results The mean age was 46.11 ± 17.16 years of them 58.25% were males. 2.9% patients had COVID-19-related symptoms and 97.1% were asymptomatic. All symptomatic patients tested positive for COVID-19 IgM antibody and RT-PCR. Among asymptomatic patients 23% had positive COVID-19 antibodies, of them 56.5%patients had positive RT-PCR. One HCW developed COVID-19 during the study. None of the included patients developed new onset of COVID-19 infection, two weeks after the procedure. Conclusion COVID-19 antibody test may be a reasonable preprocedural screening method for low-income countries and COVID-19 RT-PCR screening for symptomatic patients and those with positive COVID-19 antibody test. |
first_indexed | 2024-12-23T23:17:00Z |
format | Article |
id | doaj.art-4a08f5829bd849c4ab5a77a71dae29e9 |
institution | Directory Open Access Journal |
issn | 2090-6226 |
language | English |
last_indexed | 2024-12-23T23:17:00Z |
publishDate | 2022-02-01 |
publisher | SpringerOpen |
record_format | Article |
series | Egyptian Liver Journal |
spelling | doaj.art-4a08f5829bd849c4ab5a77a71dae29e92022-12-21T17:26:29ZengSpringerOpenEgyptian Liver Journal2090-62262022-02-011211810.1186/s43066-022-00177-0COVID-19 screening before gastrointestinal proceduresAhmed Eliwa0Osman Mohamed Osman1Ahmed Helal2Abdelgawad Saied Mohamed3Mohammed ElFayoumie4Ramadan Eldamarawy5Sadek Mostafa6Ashraf Elsharkawy7Khaled S. Makboul8Salwa I. Elshennawy9Mahmoud Abdelhady10Ashraf Elbahrawy11Department of Internal Medicine, Al-Azhar UniversityDepartment of Internal Medicine, Al-Azhar UniversityDepartment of Internal Medicine, Al-Azhar UniversityDepartment of Internal Medicine, Al-Azhar UniversityDepartment of Internal Medicine, Al-Azhar UniversityDepartment of Internal Medicine, Al-Azhar UniversityDepartment of Internal Medicine, Al-Azhar UniversityDepartment of Internal Medicine, Al-Azhar UniversityDepartment of Internal Medicine, Al-Azhar UniversityDepartment of Clinical Pathology, Faculty of Medicine (for girls), Al-Azhar UniversityDepartment of Surgery, Al-Azhar UniversityDepartment of Internal Medicine, Al-Azhar UniversityAbstract Background In March 2020, the World Health Organization declared coronavirus 2019 (COVID-19) a global pandemic. We aimed to assess the ability of COVID-19 screening to detect preprocedural infection at the gastrointestinal units. One hundred and three patients indicated for gastrointestinal tract interventional procedures were included. All patients surveyed for COVID-19-related symptoms and COVID-19 rapid IgM/IgG antibodies. Symptomatic and COVID-19 antibody-positive patients further tested for COVID-19 reverse transcriptase by polymerase chain reaction (RT-PCR). All patients contacted, 14 days after the procedure and asked about the possible development of COVID-19. All health care workers (HCWs) (n=18) were screened weekly for COVID-19-related symptoms. Results The mean age was 46.11 ± 17.16 years of them 58.25% were males. 2.9% patients had COVID-19-related symptoms and 97.1% were asymptomatic. All symptomatic patients tested positive for COVID-19 IgM antibody and RT-PCR. Among asymptomatic patients 23% had positive COVID-19 antibodies, of them 56.5%patients had positive RT-PCR. One HCW developed COVID-19 during the study. None of the included patients developed new onset of COVID-19 infection, two weeks after the procedure. Conclusion COVID-19 antibody test may be a reasonable preprocedural screening method for low-income countries and COVID-19 RT-PCR screening for symptomatic patients and those with positive COVID-19 antibody test.https://doi.org/10.1186/s43066-022-00177-0COVID-19EndoscopyGITCOVID-19 antibodyRT-PCRPandemic |
spellingShingle | Ahmed Eliwa Osman Mohamed Osman Ahmed Helal Abdelgawad Saied Mohamed Mohammed ElFayoumie Ramadan Eldamarawy Sadek Mostafa Ashraf Elsharkawy Khaled S. Makboul Salwa I. Elshennawy Mahmoud Abdelhady Ashraf Elbahrawy COVID-19 screening before gastrointestinal procedures Egyptian Liver Journal COVID-19 Endoscopy GIT COVID-19 antibody RT-PCR Pandemic |
title | COVID-19 screening before gastrointestinal procedures |
title_full | COVID-19 screening before gastrointestinal procedures |
title_fullStr | COVID-19 screening before gastrointestinal procedures |
title_full_unstemmed | COVID-19 screening before gastrointestinal procedures |
title_short | COVID-19 screening before gastrointestinal procedures |
title_sort | covid 19 screening before gastrointestinal procedures |
topic | COVID-19 Endoscopy GIT COVID-19 antibody RT-PCR Pandemic |
url | https://doi.org/10.1186/s43066-022-00177-0 |
work_keys_str_mv | AT ahmedeliwa covid19screeningbeforegastrointestinalprocedures AT osmanmohamedosman covid19screeningbeforegastrointestinalprocedures AT ahmedhelal covid19screeningbeforegastrointestinalprocedures AT abdelgawadsaiedmohamed covid19screeningbeforegastrointestinalprocedures AT mohammedelfayoumie covid19screeningbeforegastrointestinalprocedures AT ramadaneldamarawy covid19screeningbeforegastrointestinalprocedures AT sadekmostafa covid19screeningbeforegastrointestinalprocedures AT ashrafelsharkawy covid19screeningbeforegastrointestinalprocedures AT khaledsmakboul covid19screeningbeforegastrointestinalprocedures AT salwaielshennawy covid19screeningbeforegastrointestinalprocedures AT mahmoudabdelhady covid19screeningbeforegastrointestinalprocedures AT ashrafelbahrawy covid19screeningbeforegastrointestinalprocedures |